Concepedia

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer

Taira Kinoshitá, Atsushi Nashimoto, Yoshitaka Yamamura, Takeshi Okamura, Mitsuru Sasako, Junichi Sakamoto, Hiroshi Kojima, Masahiro Hiratsuka, Kuniyoshi Arai, Motonori Sairenji,

Gastric Cancer · 2004 · 45 citations · 6 references

DOIFull text

Open access

Concepts

References

6

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

John S. Macdonald, Stephen R. Smalley, Jacqueline Benedetti et al. · New England Journal of Medicine · 2001 · 3.5K citations

, , +17

Progress in gastric cancer surgery in Japan and its limits of radicality

Keiichi Maruyama, Kenzo Okabayashi, Taira Kinoshitá · World Journal of Surgery · 1987 · 682 citations

, , +11

Gastric cancer treatment guidelines in Japan

Toshifusa Nakajima · Gastric Cancer · 2002 · 582 citations · Full text

, , +12

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Yuh Sakata, Atsushi Ohtsu, N Horikoshi et al. · European Journal of Cancer · 1998 · 564 citations

, , +11

Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

Wasaburo Koizumi, Minoru Kurihara, Shuji Nakano et al. · Oncology · 2000 · 440 citations

, , +15